CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

about

The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer Down-regulation of CXCL 11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition

P2860

Q57492052-C7751924-73BD-45F5-BF1D-6512FB2FF501 Q58694406-A3A51462-FDDB-4CD4-B63B-579C41D49D99

P2860

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

Item

http://www.wikidata.org/entity/Q45931583

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@en

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@nl

type

Item

label

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@en

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@nl

prefLabel

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@en

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@nl

P1476

CXCL9, CXCL10, CXCL11/CXCR3 ax ...... rget for novel cancer therapy.

@en

P2093

Heinz-Josef Lenz

http://www.w3.org/2001/XMLSchema#string

Hideo Baba

http://www.w3.org/2001/XMLSchema#string

Martin D Berger

http://www.w3.org/2001/XMLSchema#string

Michelle McSkane

http://www.w3.org/2001/XMLSchema#string

Ryuma Tokunaga

http://www.w3.org/2001/XMLSchema#string

Shivani Soni

http://www.w3.org/2001/XMLSchema#string

Wu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

Exploring the full spectrum of macrophage activation

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11

Regulation of interferon-gamma during innate and adaptive immune responses

Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors

Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha

Mig and IP-10: CXC chemokines that target lymphocytes

P304

40-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.CTRV.2017.11.007

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Puccini

Madiha Naseem

P577

2017-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207310

http://www.w3.org/2001/XMLSchema#string

P932

5801162

http://www.w3.org/2001/XMLSchema#string

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

about

P2860

P2860

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932